Company profile: Arbor Biosciences
1.1 - Company Overview
Company description
- Provider of genomics and synthetic biology products and services, including myTXTL cell-free protein expression kits, myBaits hybridization capture probes, targeted next-generation sequencing kits, cytogenetics in situ hybridization probes, and DNA/RNA sequencing and bioinformatics services.
Products and services
- MyBaits Hybridization Capture Probes: Arbor Biosciences engineers custom-engineered hybridization probes that enrich specific DNA or RNA targets from complex samples for next-generation sequencing
- MyTXTL Kits: Arbor Biosciences produces industrial-grade cell-free protein expression systems enabling rapid and parallel production of proteins, enzymes, and other biological structures for molecular biology applications
- Targeted Next-Generation Sequencing Kits: Arbor Biosciences develops and architects modular kits designed for targeted sequencing applications in genomics research
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Arbor Biosciences
NEO New Oncology
HQ: Germany
Website
- Description: Provider of the NEO diagnostic platform, designed and developed by NEO New Oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NEO New Oncology company profile →
Color Health
HQ: United States
Website
- Description: Provider of a healthcare delivery platform offering clinical-grade genetic testing for cancer and heart risk, cancer care management, cardiometabolic care, and COVID-19 testing, vaccination, and treatment with telehealth and prescription delivery, plus a research platform with genetic sequencing, bioinformatics, and participant engagement for large-scale health initiatives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Color Health company profile →
Applied Microarrays
HQ: United States
Website
- Description: Provider of design, optimization and manufacturing services for DNA and protein biosensors and other microarrays on glass, plastic and semiconductors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied Microarrays company profile →
Radient Pharma
HQ: United States
Website
- Description: Provider of cancer diagnostic tests and proprietary cancer vaccine technology, offering Onko-Sure, an in vitro blood test to detect and monitor solid tumor cancers by measuring Fibrin and Fibrinogen Degradation Products, and Combination Immunogene Therapy (CIT), designed to enhance the immune system’s ability to destroy cancer cells by incorporating genes into tumor cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Radient Pharma company profile →
Guardant Health
HQ: United States
Website
- Description: Provider of precision oncology diagnostics, including Shield, an FDA-approved blood test for colorectal cancer screening; Guardant Reveal for MRD in early-stage cancers; Guardant360 CDx, an FDA-approved liquid biopsy for comprehensive genomic profiling in advanced solid tumors; Guardant360 Response for treatment monitoring; Guardant360 TissueNext with AI-powered PD-L1 detection; and Guardant Infinity for biomarker discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Guardant Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Arbor Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Arbor Biosciences
2.2 - Growth funds investing in similar companies to Arbor Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Arbor Biosciences
4.2 - Public trading comparable groups for Arbor Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →